Strategies that delay or prevent the timely availability of affordable generic drugs in the United States

Gregory H. Jones, Michael A. Carrier, Richard T. Silver and Hagop Kantarjian


High cancer drug prices are influenced by the availability of generic cancer drugs in a timely manner. Several strategies have been used to delay the availability of affordable generic drugs into the United States and world markets. These include: reverse payment or pay-for-delay, patent settlements, authorize generics, product hopping, lobbying against cross-border drug importation, buying out the competition, and others. In this Forum, we detail these strategies and how they can be prevented.

  • Submitted November 5, 2015.
  • Accepted December 10, 2015.